These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8031564)

  • 1. A comparison of the performance of pig hearts perfused with pig or human blood using an ex-vivo working heart model.
    Dunning JJ; Pierson RN; Braidley PC; White DJ; Wallwork J
    Eur J Cardiothorac Surg; 1994; 8(4):204-6. PubMed ID: 8031564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of hyperacute rejection of pig hearts by human blood using an ex vivo perfusion model.
    Dunning J; Braidley PC; Wallwork J; White DJ
    Transplant Proc; 1994 Apr; 26(2):1016-7. PubMed ID: 8171452
    [No Abstract]   [Full Text] [Related]  

  • 3. Combining the hDAF transgene with the GP IIb/IIIa inhibitor tirofiban improves heart performance and reduces myocardial damage following hyperacute rejection in an ex vivo perfusion model.
    Brandl U; Erhardt M; Joeckle H; Michel S; Brenner P; Bittmann I; Roessle M; Mordstein V; Hammer C; Schmoeckel M; Reichart B
    Transplant Proc; 2005; 37(1):491-2. PubMed ID: 15808686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of human anti-porcine "natural antibodies" recovered from ex vivo perfused hearts--predominance of IgM and IgG2.
    Ross JR; Kirk AD; Ibrahim SE; Howell DN; Baldwin WM; Sanfilippo FP
    Transplantation; 1993 May; 55(5):1144-50. PubMed ID: 8497896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of natural IgM in the hyperacute rejection of discordant heart xenografts.
    Gambiez L; Salame E; Chereau C; Calmus Y; Cardoso J; Ayani E; Houssin D; Weill B
    Transplantation; 1992 Oct; 54(4):577-83. PubMed ID: 1412747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of hyperacute rejection by human decay accelerating factor in xenogeneic perfused working hearts.
    Schmoeckel M; Nollert G; Shahmohammadi M; Young VK; Chavez G; Kasper-König W; White DJ; Müller-Höcker J; Arendt RM; Wilbert-Lampen U; Hammer C; Reichart B
    Transplantation; 1996 Sep; 62(6):729-34. PubMed ID: 8824468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pig analogue of CD59 protects transgenic mouse hearts from injury by human complement.
    Fisicaro N; Aminian A; Hinchliffe SJ; Morgan BP; Pearse MJ; D'Apice AJ; Cowan PJ
    Transplantation; 2000 Sep; 70(6):963-8. PubMed ID: 11014650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of ischemic time on hyperacute xenograft rejection of pig hearts in a working heart perfusion model with human blood.
    Brenner P; Hinz M; Huber H; Schmoeckel M; Reichenspurner H; Meiser B; Hammer C; Reichart B
    Transpl Int; 2000; 13 Suppl 1():S494-503. PubMed ID: 11112061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfusion of rabbit hearts with pig blood results in complement mediated hyperacute xenograft rejection.
    Forty J; White DJ; Wallwork J
    Transpl Int; 1992; 5 Suppl 1():S318-9. PubMed ID: 14621811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody removal by column immunoabsorption prevents tissue injury in an ex vivo model of pig-to-human xenograft hyperacute rejection.
    Kroshus TJ; Dalmasso AP; Leventhal JR; John R; Matas AJ; Bolman RM
    J Surg Res; 1995 Jul; 59(1):43-50. PubMed ID: 7630135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble Galalpha(1,3)Gal conjugate combined with hDAF preserves morphology and improves function of cardiac xenografts.
    Brandl U; Erhardt M; Michel S; Jöckle H; Burdorf L; Bittmann I; Rössle M; Mordstein V; Brenner P; Hammer C; Reichart B; Schmoeckel M
    Xenotransplantation; 2007 Jul; 14(4):323-32. PubMed ID: 17669174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation.
    Kroshus TJ; Rollins SA; Dalmasso AP; Elliott EA; Matis LA; Squinto SP; Bolman RM
    Transplantation; 1995 Dec; 60(11):1194-202. PubMed ID: 8525509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo characterization of human anti-porcine hyperacute cardiac rejection.
    Kirk AD; Heinle JS; Mault JR; Sanfilippo F
    Transplantation; 1993 Oct; 56(4):785-93. PubMed ID: 8212196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced fibrin deposition and intravascular thrombosis in hDAF transgenic pig hearts perfused with tirofiban.
    Brandl U; Jöckle H; Erhardt M; Michel S; Burdorf L; Brenner P; Bittmann I; Rössle M; Mordstein V; Hammer C; Thein E; Reichart B; Schmoeckel M
    Transplantation; 2007 Dec; 84(12):1667-76. PubMed ID: 18165780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of cardiac function of discordant heart xenografts using a blood-perfused, isolated, supported heart model].
    Miyatake T
    Hokkaido Igaku Zasshi; 1994 Jan; 69(1):35-45. PubMed ID: 8119656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypodermin A, a new inhibitor of human complement for the prevention of xenogeneic hyperacute rejection.
    Malassagne B; Regimbeau JM; Taboit F; Troalen F; Chéreau C; Moiré N; Attal J; Batteux F; Conti F; Calmus Y; Houssin D; Boulard C; Houdebine LM; Weill B
    Xenotransplantation; 2003 May; 10(3):267-77. PubMed ID: 12694547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperacute lung rejection in a pig-to-human transplant model: the role of anti-pig antibody and complement.
    Pierson RN; Kasper-Konig W; Tew DN; Young VK; Dunning JJ; Horsley J; Carey NR; Wallwork J; White DJ
    Transplantation; 1997 Feb; 63(4):594-603. PubMed ID: 9047157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin inhibition in an ex vivo model of porcine heart xenograft hyperacute rejection.
    Robson SC; Young VK; Cook NS; Metternich R; Kasper-Konig W; Lesnikoski BA; Pierson RN; Hancock WW; Candinas D; White DJ; Bach FH
    Transplantation; 1996 Mar; 61(6):862-8. PubMed ID: 8623150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A soluble chimeric inhibitor of C3 and C5 convertases, complement activation blocker-2, prolongs graft survival in pig-to-rhesus monkey heart transplantation.
    Salerno CT; Kulick DM; Yeh CG; Guzman-Paz M; Higgins PJ; Benson BA; Park SJ; Shumway SJ; Bolman RM; Dalmasso AP
    Xenotransplantation; 2002 Mar; 9(2):125-34. PubMed ID: 11897005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective IgM depletion prolongs organ survival in an ex vivo model of pig-to-human xenotransplantation.
    Kroshus TJ; Bolman RM; Dalmasso AP
    Transplantation; 1996 Jul; 62(1):5-12. PubMed ID: 8693544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.